Abstract-Effects of sulpiride on the central nervous system were studied in catalepsy induction (I) and antagonism to gnawing behaviour (I1) induced by apomorphine and methamphetamine in normal rats, and in antagonism to rotational behaviour (II1) induced by apomorphine and methamphetamine in rats with substantia nigra uni laterally lesioned chronically by microinjection of 6-hydroxydopamine. Sulpiride was administered orally and intraventricularly, and the effects of sulpiride were com pared to those of haloperidol and chlorpromazine administered through the same routes. In oral administration, sulpiride was almost inactive in (1), and was several hundreds to a thousand times less potent than haloperidol in (II) and (III), while chlor promazine was 20 to 150 times stronger than sulpiride. In intraventricular admin istration, sulpiride was almost equipotent to haloperidol in (I), and was equally effective to or 2 to 3 times more effective than halopridol in (III), although several times less potent than haloperidol in (I1), and chlorpromazine was least potent among the drugs in all respects. These findings suggest that sulpiride is essentially a potent inhibitory substance on dopamine receptors in the central nervous system and the rather weak central effects of peripherally given sulpiride are due to poor penetration through the blood brain barrier.
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In the last decade, several authors have reported that sulpiride, N-ethyl-2-(2-methoxy 5-sulphonamidobenzamidomethyl)-pyrrolidine, may be useful for therapy of schizophrenia, depressive syndrome, psychoses and other mental diseases (1- 7) , and that the drug apparently has fewer extrapyramidal side effects.
Pharmacologically, sulpiride has been characterized by a strong inhibitory effect on apomorphine-induced emesis in dogs (8, 9) , which was about 150 times more potent than that of chlorpromazine after subcutaneous or oral administration. In rats, on the other hand, the drug is much less effective in causing catalepsy and in antagonizing the stereotyped behaviour induced by apomorphine, amphetamine, methamphetamine and nomifensine, and in antagonizing the hyperactivity induced by dopamine injected into the nucleus ac cumbens septi (10) (11) (12) . The rather weak central effects of peripherally given sulpiride in rats may be explained by poor penetration into the central nervous system. There is also further evidence that sulpiride is a potent anti-dopaminergic drug, when tested for antagonism to dopamine-induced pancreatic juice secretion in dogs (in preparation).
We attempted to evaluate anti-dopamine activity of sulpiride in the central nervous system after intraventricular administration of the drug. The activity of intraventricular close of the drug was investigated in catalepsy induction and antagonism to gnawing be haviour induced by apomorphine and methamphetamine in normal rats , and in antagonism to rotational behaviour induced by apomorphine and methamphetamine in rats with uni lateral lesions of the substantia nigra . Rats with unilateral degeneration of the nigro striatal system reportedly respond to dopaminergic stimulants and characteristic rotational behaviour which ensues can be suppressed by neuroleptic drugs (13) (14) (15) kg). The control animals were given 0.9 NaCI only.
Immediately after the injection of apomorphine or methamphetamine, the rats ~%ere In the oral administration experiment, the rats once used in a pair of experiments were again used for another pair of experiments more than one week after the former experiments, and no great change was seen in the control values. The animals could be re-used in this way repeatedly during six months. In the intraventricular adminis tration experiment, however, the rat was used for only one pair of experiments.
Inirarentricular administration of test drug
Test drug in a volume of 10 ,,l was injected at a rate of 2 ,d/sec into a single side of the lateral ventricle, which was 2 nom lateral from the bregma and 3 nom deep from the skull surface of the animal. The procedure of operation and injection was the same as described in the section of "Lesion o/ the substantia -l utoradio raphic stud r'
To investigate a transfer of sulpiride from the ventricle to the brain, '4C-sulpiride (labelled at carbonyl carbon atom) was injected intraventricularly to rats (male Sprague Dawley, 5 weeks old, weighing approx. 100 g) at a dose of 32 'tg (0.25 ,tC]) in 10 dal. At various times (5, 15, 30, 60 and 120 min) after the injection, the rats were frozen to death by a dry ice-acetone mixture. Autoradiography was carried out according to the method described by Ullberg (19) . A sagittal dissection of the frozen head was carried out near the injected point. The dissected slice in 30 ,, thickness was mounted on Sakura Industrial Calculation and statistical analysis
The ED50 value was computed by the probit analysis (20) . The significance of the difference between the means of the response was evaluated by Student's t-test.
RESULTS

Catalepsy induction
Oral administration: Results are shown in Table 1 . Sulpiride did not display a distinct cataleptic effect even at a dose as high as 2,000 mg/kg. Chlorpromazine caused a According to the dose required to produce a 50% catalepsy (ED50), sulpiride was almost as active as haloperidol and six times more effective than chlorpromazine.
Antagonism to aponwrplrine and mcthanlplietamine-indtreed gnawing behaviour
Oral administration: Orally given sulpiride displayed an inhibitory effect in a dose dependent manner on both apomorphine and methamphetamine-induced gnawing be haviour at 4 hr, but not at 1 hr after the administration, and was more effective against The apomorphine-induced gnawing behaviour was suppressed by 53 with 250 /eg/rat of sulpiride, while chlorpromazine at the same dose was only slightly effective (about 10'/,, inhibition) in suppressing the gnawing behaviour (Fig. 3) . At lower doses, sulpiride and chlorpromazine had no effect on the gnawing behaviour. Haloperidol showed marked inhibitory effects at doses of 64 and 250 ; tg/rat. According to the ED50 values, sulpiride was about four times less effective than haloperidol.
The test drugs were apparently more effective in inhibiting the methamphetamine induced gnawing behaviour. Sulpiride 64 ,eg, haloperidol 16 ,eg and chlorpromazine 250 ,ig/rat inhibited distinctly the gnawing behaviour. Sulpiride suppressed the gnawing behaviour completely at a dose of 250 ,eg/rat (Fig. 4) . According to the ED50 values, sulpiride was about four times less effective than haloperidol and was three times or more effective than chlorpromazine. Blockade of apomorphine-induced rotational belrariour of rats levioned unilaterally in the substantia nigra
Oral administration: Effects of test drugs given orally on the apomorphine-induced rotational behaviour are presented in Table 3 . Sulpiride was significantly effective in inhibiting the rotational behaviour, although high doses of 500 and 2,000 mg/kg were required. The inhibition was more intense at 4 hr after the administration than at 1 hr.
Haloperidol and chlorpromazine exhibited a significant inhibition in doses ranging from 4 to 32 mg/kg. Their inhibitory effects were almost comparable 1 hr and 4 hr after admin istration, suggesting a more rapid absorption of haloperidol and chlorpromazine from the digestive tract. According to the dose required to produce 50°o inhibitory effect (ED50),
Sulpiride was 200 and 65 times less effective than haloperidol and chlorpromazine, respec tively, at 4 hr after the administration. Blockade of niet{ramphetamine-induced rotational behaviour of rats lesioned unilaterally in the substantia nigra
Oral administration: Although sulpiride inhibited the methamphetamine-induced rotation more potently than the apomorphine-induced rotation, still the dose as high as 500 mg/kg was requested for the significant inhibitory effect (Table 5) . Haloperidol also exhibited a stronger inhibitory effect in the former rotation than in the latter. Chlor promazine inhibited the methamphetarnine-induced rotation equally to the apomorphine induced rotation. According to ED50 values, sulpiride was 900 and 20 times less effective than haloperidol and chlorpromazine, respectively, at 4 hr after the administration. A low dose (125 mg/kg) of sulpiride appeared to enhance slightly the rotational behaviour at an early time (1 hr) after the administration.
Intraventricular administration: Intraventricularly dosed sulpiride exhibited a pro nounced inhibitory effect on the methamphetamine-induced rotational behaviour and appeared to be more effective than haloperidol ( Table 6 ). As seen after oral administration, sulpiride as well as haloperidol suppressed the rotational behaviour more strongly than did the apomorphine-induced rotation. Inhibitory effect of chlorpromazine on the metham phetamine-induced rotation was comparable to that on the apomorphine-induced rotation.
According to ED50 values, sulpiride was almost three and thirty times more effective than haloperidol and chlorpromazine, respectively.
Transfer of sulpiride from the cerebral ventricle to the neostriatal area From 5 to 15 min after the injection of 14C-labelled sulpiride into the lateral ventricle, the drug dispersed rapidly over the subarachnoid space especially close to the cerebellum, probably through the fourth ventricle. From 30 to 60 min after the administration, a pro gressive penetration of sulpiride into the neostriatal area was found.
There was no practical difference between 60 and 120 min in apparent density of the drug at the neostriatal area.
A typical autoradiographic picture at 5 and 60 min is presented in Figs. 5A and 513, respec
tively. An illustrative drawing of a sagittal section of rat brain is also presented in Fig. 5C .
DISCUSSION
The parameters studied in the present paper for evaluating the effect of neuroleptic drugs; i.e., catalepsy induction, apomorphine and methamphetamine-induced compulsory Neuroleptic drugs produce a characteristic catalepsy in rats, as reported by Janssen et al. (21) . Although the mechanism whereby neuroleptics induce the catalepsy has yet to be clarified, considerable evidence suggests that a suppression of dopamine functions in the corpus striatum is associated with induction of the catalepsy. (36, 38, 39) . These findings suggest that apomorphine and amphetamine-induced stereotyped behaviour is a doonaHminergic phenomenon in the corpus striatum, although the possibility of' some adrenc.._ic input in the phenomenon has to be considered (31 ) . Me thamphetamine, used in present study, was reported to produce stereotypy similar in all respects to that seen after amphetamine (40) .
There a:e many reports describing that directly or indirectly acting dopaminergic stimu lants evoke a remarkable rotational behaviour in rats with unilateral lesions of the nigro neostriatal pathway.
In chronically lesioned rats. apomorphine, a dopamine receptor stimulating drug, causes the animals to rotate towards the unlesioned side, while amphe tamine. a dopamine releasing drug, causes them to rotate towards the lesioned side. From the present findings, sulpiride is postulated to be essentially a potent inhibitory substance on dopamine receptors in the central nervous system. This assumption is sup ported by the finding that subcutaneous injection of sulpiride to rats and rabbits resulted in a selective increase of dopamine turnover in the brain (47) , and such is considered to be a consequence of a compensatory feed back mechanism following the blockade of the post synaptic dopamine receptors (22, 46, 48) . The inhibitory effect of supiride on the brain dopamine mechanisms may play a role in the antipsychotic performance.
Different from the findings with intraventricular administration experiments, sulpiride given orally to rats revealed far weaker effects than haloperidol and chlorpromazine on the indices for central dopamine functions, although sulpiride was readily absorbed from the digestive tract (unpublished). This finding is compatible with the fact that in clinical trials, rather high doses of sulpiride are required to attain appraisable antipsychotic effects (2, 3,
5, 7)
. Thus it appears difficult for sulpiride to penetrate the blood brain barrier and enter the central nervous system.
